EuroScience.Net

This week in European sciences -- week 40|2004
 

Reassessment of Traveling Genetically Modified Grass
New York Times 30.9.2004
"There is no evidence yet that any of the genetically engineered crops already in wiedeuse in this country have caused any signigicant environmental harm," concludes the New York Times in an editorial piece (30.9.2004). Modified corn, soybeans and cotton are widely produces in the U.S. Now, scientists found that the genes of genetically engineered grass, a creeping bentgrass, migrate much farther than anyone had thought possible - more than 15km away from the trial field. Although, there are more urgent environmental problems, as the NY Times stresses, it's good that an official full-scale environmental impact assessment is scheduled for the Monsanto plant.

Dogs Sniff Right the Cancer from Your Urine
New York Times 28.9.2004
Sounds like an April fool's day's top story, researchers found that dogs may sniff rather good whether your urine probe yields the smell - supposedly by formaldehyde, alkanes and benzene derivates - of cancer. The study was published in the British medical journal. Donald G. McNeil Jr. goes for the NY Times (28.9.2004) into the issue and devides science from fiction.

Particle Physics Across the Borders
Neue Zürcher Zeitung 29.9.2004
50 years ago an outstanding European, better: global research institution has been founded, the "the gigantic pan-European particle physics research centre, Cern, buried in a 27km ring under the border between Switzerland and France", as the Guardian puts it in an editorial. The Conseil Européen pour la Recherche Nucléaire is granted a success story by a feature article in Neue Zürcher Zeitung for several reasons: Cern is a successful pan-European project with global relevance, scientists from all over the world spend their time and exchange their spirits. It brought European research back on a competitive stage after the II. World War. The competition between Cern and U.S. institutions, the Brookhaven National Lab in New York and the Fermilab in Chicago, gave plenty of outstanding results, including Noble prizes, and also many interesting stories to tell. Also the internet and HTML coding of web pages have been invented and applied by the particle physicists over there. Now, experiments in Geneva have ceased due to the construction of the next, biggest-ever international linear collider. This Large Hadron Collider (LHC) will go into service in three years and - hopefully - uncover the existence of the Higgs particle that is associated with matter and leading to its mass. Also the U.S., Russia and Japan spend a 12 percent of its total costs of 3 billion euros.

Recording Miracle Cures
The Guardian 30.9.2004
Laura Spinney visits Lourdes (France) and profiles the official medic of the place, Dr Patrick Theillier, whose job is to "welcome pilgrims, doctors and carers from all over the world", but especially records the many unexplained cures - working in a "position at the boundary of science and faith".

Sciences are a Net Gain to Economy
The Guardian 30.9.2004
As fewer British students take science courses the closure of university departments has now a matter of growing concern in the British scientific community. Rebecca Smithers reports in The Guardian (30.9.2004) whether the proposed funding subsidies by education secretary Charles Clarke will bring an end to the crisis. According to studies the number of university physics courses dropped by 18 percent between 1994 to 2001, in materials sciences by 33 percent. High profile departments in chemistry closed at King's College London and Queen Mary University London. But British nobel laureate (in chemistry) Sir Harry Kroto sees a renaissance in chemistry. The number of students has risen in recent years, and research from Germany shows - according to Kroto - that "the sciences are a net gain to the economy, while the arts and media are a net loss, because far more people take them up than there are jobs."

Supercomputing Competition Yields New Record
New York Times 29.9.2004
The race for ever higher performance in computing yields a new benchmark record by a machine of IBM with 16,000 processors, reports John Markoff in the NY Times (29.9.2004). It exceeds the Japanese Earth Simulator by 'just a few' calculations per seconds, but it is awaited that the fully installed BlueGene/L system with roughly 130,000 processors will even do better. Markoff explained that "supercomputing technologies were widely viewed as indicators of national industrial powers in the 1980's and 1990's. They are used extensively in weapons design." In the U.S. - you have to add, while the Japanese machine was used for civil simulations, for instance, climate change models. Eventually, the most important progress has been done by IBM in reducing drastically the size and the power consumption (per computation). Although corporate and academic researchers rely heavily on high performance computer applications there's no relevant research and production in supercomputers themselves being done in Europe.

The Many Lifes of a Shark
Frankfurter Allgemeine Zeitung 27.9.2004
As an interesting example of stem cell research Joachim Müller-Jung describes in FAZ (27.9.2004) the work of Hermann Haller at Hannover university, Germany, who examines the kidneys of sharks. Sharks may regenerate their kidneys when necessary. Researchers have found a regenerative zone around the shark's kidney with a huge reservoir of stem cells with a rescue programme included. How it works is unknown. Müller-Jung adds that just in recent week the first stem cells have been discovered in human kidney - but their amount and function is still unclear. Now, hope comes up that basic stem cell research may eventually give clues for a better treatment of patients with dysfunctional kidneys.

All He Can Do, for the People and Company
The Guardian 23.9.2004
Sarah Boseley talks to Hank McKinnell, the CEO of Pfizer, the world's largest drug company, and asks for his position in the fight against Aids/HIV. McKinnell was the only drug company boss at the recent international Aids conference in Bangkok and claims to fight against Aids due to his deep-felt responsibility to "children and grandchildren." At present, Pfizer has got two promising drug candidates against Aids in the pipeline. "I don't doubt some of them would be donated," says McKinnell, but it depends on the circumstances of each market and each individual product. He also criticised European countries for their healthcare policies. Pfizer has already closed research centers in France, Germany and Italy. Pfizer may only supply cheap or donated drugs to Aids-affected countries when the rich countries pay for the drugs on a market level. According to him, when European countries insist on ever-lower prices, "they've basically become countries that don't welcome innovation."

Your Next Space Trip Endangers Your Health
The Guardian 23.9.2004
Isolation, nausea, kidney stones - these are the realities for a space trip, for instance, to our next neighbour Mars. Tim Radford investigates in the Guardian (23.9.2004) what will happen to your body physically and mentally when you explore space.

Iraqi Science After 'Shock And Awe'
The Guardian 23.9.2004
Luke Harding reports from Baghdad what left in Iraqi science after Saddam, international sanctions and the U.S.'s 'shock and awe' strike. Scientists are demoralised, most equipment is 20 or 30 years old and should be in a museum. Looters carried off everything they could. Now, female and male students sit together in Baghdad university. But after a radical Islamist group demanded than men and women should be taught separately, guards with machine guns are posted at all entrances. Most Iraqi scientists graduated in western countries, especially the U.S. and UK. Now they hope for help and try to re-establish international contacts with the scientific community.
In addition, Brian Whitaker gives an overview what fruitful developments and achievments Iraqi science contributed to the world in the past 5000 years - algebra, optics, windmills. Iraq was a key center of ancient scientific knowledge. It "went into decline, partly for reasons that are familiar today: religious rivalries and problems with internal security," writes Whitaker.
 

 

feedback
subscribe
unsubscribe

Feedback

We are glad to receive your comments! Send us an e-mail | subscribe | unsubscribe